Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Ahearn

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Cell and Developmental Biology|August 6, 2019
Reprogramming the Epigenome With Vitamin CTaylor Lee Chong, Emily L Ahearn, Luisa Cimmino
International Journal of Dermatology|October 22, 2022
Psoriasiform and lichenoid eruptions as a potential harbinger of bullous dermatoses in the setting of immune checkpoint inhibitors: a case seriesEmily L Ahearn, Annika Belzer, Stephanie R Cohen, et al.
The Journal of Rheumatology|July 3, 2023
Measuring What Matters: A Qualitative Study of the Relevance and Clinical Utility of PROMIS Surveys in Systemic Lupus ErythematosusShanthini Kasturi, Emily L Ahearn, Adena Batterman, et al.
Cell Reports|October 2, 2025
Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activationTiffany E Leesang, John P Brabson, Yoon Sing Yap, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|August 6, 2019
Reprogramming the Epigenome With Vitamin CTaylor Lee Chong, Emily L Ahearn, Luisa Cimmino
International Journal of Dermatology|October 22, 2022
Psoriasiform and lichenoid eruptions as a potential harbinger of bullous dermatoses in the setting of immune checkpoint inhibitors: a case seriesEmily L Ahearn, Annika Belzer, Stephanie R Cohen, et al.
The Journal of Rheumatology|July 3, 2023
Measuring What Matters: A Qualitative Study of the Relevance and Clinical Utility of PROMIS Surveys in Systemic Lupus ErythematosusShanthini Kasturi, Emily L Ahearn, Adena Batterman, et al.
Cell Reports|October 2, 2025
Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activationTiffany E Leesang, John P Brabson, Yoon Sing Yap, et al.
Pageof 1